| 000 | 01790 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513124626.0 | ||
| 264 | 0 | _c19971002 | |
| 008 | 199710s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm970020k _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSall, D J | |
| 245 | 0 | 0 |
_aUse of conformationally restricted benzamidines as arginine surrogates in the design of platelet GPIIb-IIIa receptor antagonists. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cAug 1997 |
||
| 300 |
_a2843-57 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aArginine |
| 650 | 0 | 4 |
_aBenzamidines _xchemical synthesis |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aFibrinogen _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndicators and Reagents |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 | _aMolecular Structure |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xchemical synthesis |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 700 | 1 | _aArfsten, A E | |
| 700 | 1 | _aBastian, J A | |
| 700 | 1 | _aDenney, M L | |
| 700 | 1 | _aHarms, C S | |
| 700 | 1 | _aMcCowan, J R | |
| 700 | 1 | _aMorin, J M | |
| 700 | 1 | _aRose, J W | |
| 700 | 1 | _aScarborough, R M | |
| 700 | 1 | _aSmyth, M S | |
| 700 | 1 | _aUm, S L | |
| 700 | 1 | _aUtterback, B G | |
| 700 | 1 | _aVasileff, R T | |
| 700 | 1 | _aWikel, J H | |
| 700 | 1 | _aWyss, V L | |
| 700 | 1 | _aJakubowski, J A | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 40 _gno. 18 _gp. 2843-57 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm970020k _zAvailable from publisher's website |
| 999 |
_c9267020 _d9267020 |
||